NFKBIA 抗体 (AA 32-291)
-
- 抗原 See all NFKBIA 抗体
- NFKBIA (Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, alpha (NFKBIA))
-
抗原表位
- AA 32-291
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This NFKBIA antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunoprecipitation (IP)
- 原理
- Mouse monoclonal antibody raised against partial recombinant NFKBIA .
- 交叉反应
- 人, 小鼠
- 免疫原
- Recombinant protein corresponding to amino acids 32-291 of human NFKBIA.
- 克隆位点
- 6A920
- 亚型
- IgG1
- Top Product
- Discover our top product NFKBIA Primary Antibody
-
-
- 应用备注
- The optimal working dilution should be determined by the end user.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- In PBS (0.05 % BSA, 0.05 % sodium azide)
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type ..." in: Immunology, Vol. 124, Issue 2, pp. 198-205, (2008) (PubMed).
: "BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway." in: Blood, Vol. 109, Issue 2, pp. 703-10, (2007) (PubMed).
: "Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia." in: Nature medicine, Vol. 13, Issue 1, pp. 70-7, (2007) (PubMed).
: "Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome." in: Oncogene, Vol. 25, Issue 47, pp. 6239-51, (2006) (PubMed).
: "Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation." in: Toxicology and applied pharmacology, Vol. 217, Issue 1, pp. 35-42, (2006) (PubMed).
: "NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins." in: Experimental and molecular pathology, Vol. 81, Issue 2, pp. 123-30, (2006) (PubMed).
: "
-
DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type ..." in: Immunology, Vol. 124, Issue 2, pp. 198-205, (2008) (PubMed).
-
- 抗原
- NFKBIA (Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, alpha (NFKBIA))
- 别名
- NFKBIA / IKBA (NFKBIA 产品)
- 别名
- IKBA antibody, MAD-3 antibody, NFKBI antibody, AI462015 antibody, Nfkbi antibody, RL/IF-1 antibody, ECI-6/IKBA antibody, NFKBIA antibody, ikbaB antibody, wu:fb81f08 antibody, zgc:56666 antibody, zgc:77616 antibody, ikbaA antibody, wu:fj16a07 antibody, zgc:85769 antibody, NFKB inhibitor alpha antibody, nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha antibody, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha b antibody, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha a antibody, NFKBIA antibody, Nfkbia antibody, nfkbiab antibody, nfkbiaa antibody
- 基因ID
- 4792
- 途径
- NF-kappaB Signaling, TCR Signaling, TLR signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Maintenance of Protein Location, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, BCR Signaling
-